Oct 3rd, 2012
Lipobay/Baycol Victim Goes To Court
Argentina: BAYER Sentenced To Pay Compensation
The pharmaceutical company BAYER has been ordered to pay 968,000 pesos (about US $206,000) to a victim of the cholesterol-lowering drug Lipobay/Baycol in Argentina. The claimant, Flavio Rein, suffered irreparable muscular damage, visual disturbances and damage to the kidneys after taking the drug for only one month.
All in all, the trial stretched out over nine years. The appeal court in Buenos Aires (Cámara Nacional de Apelaciones en lo Civil) found in August 2012 that BAYER had provided neither doctors nor patients with appropriate information about the risks of the drug, confirming a judgment from the previous year (the complete text of the judgment can be found here). The judgment became effective last week.
According to Argentinian media, this is only the second time worldwide that the company has been prosecuted in connection with Lipobay/Baycol. In the US, where numerous deaths have occurred, there have been no conclusive rulings at all so far. However, the US Supreme Court has accepted a class action against BAYER last year. BAYER has paid more than 1,000,000,000 US $ in settlements with Lipobay victims. However, these settlements did not acknowledge BAYER’s responsibility.
Philipp Mimkes from the Coalition against BAYER-Dangers said “The decision against BAYER was overdue. Company-internal documents show that the responsible managers tacitly accepted severe damage to the health of patients, even ignoring warnings from their own scientists. The conviction is of great satisfaction to all people who have been damaged.”
Patricia Venegas, Flavio Rein’s lawyer and professor of law at Buenos Aires University, says “Bayer intended to stop the sentence in the last moment by offering money, but this was 14 years too late. Flavio Rein had the courage to say no to Bayer.”
Flavio Rein was prescribed Lipobay in 1998 due to a slightly raised cholesterol level. Rein, who was completely fit apart from that, and used to exercise daily, was unable to walk for five months due to muscular damage. He is severely physically disabled today and has vision of only 30% in one eye.
We would be pleased to put you in contact with Flavio Rein (speaks Spanish) and his lawyer (Spanish and English).
For more information:
=> NY Times: Bayer Knew of Dangers of Its Cholesterol Drug
=> article Pagina 12 from Oct 1: www.pagina12.com.ar/diario/sociedad/3-204601-2012-10-01.html
=> Whistleblower Lawsuit Filed Over Baycol Fraud
=> Bayer Held Back on Drug Dangers
Coalition against BAYER Dangers (Germany)
www.CBGnetwork.org (in English)
Fax: (+49) 211-333 940 Tel: (+49) 211-333 911
please send an e-mail to receive the English newsletter "Keycode BAYER" free of charge. German/Italian/French/Spanish newsletters also available.
Prof. Juergen Junginger, designer
Prof. Dr. Juergen Rochlitz, chemist, former member of the German parliament
Wolfram Esche, attorney
Dr. Sigrid Müller, pharmacologist
Dr. Angela Spelsberg, physician, board member Transparency International
Prof. Rainer Roth, social scientist
Eva Bulling-Schroeter, member of the German parliament
Prof. Dr. Anton Schneider, biologist
Dr. Janis Schmelzer, historian,
Dr. Erika Abczynski, pediatrician
Please support us. Our international campaigns are expensive to run. We receive no public support and depend entirely on your donations.
Please send checks to:
CBG, Postfach 15 04 18, 40081 Duesseldorf, Germany
or by bank transfer to bank account number 8016533000 at GLS Bank, Germany
sort code: 43060967
BIC/SWIFT Code: GENODEM1GLS
(Bank Identifier Code)
IBAN: DE88 4306 0967 8016 5330 00
(International Bank Account Number)
Please note that bank transfers within Europe are usually no more costly than within your own country, if you quote the BIC and IBAN numbers
You may also support us online